{"product_id":"sculptra","title":"Sculptra 2x5ml","description":"\u003cstyle\u003e\n.pe-desc{\n  --pe-ink:#1C235C;\n  --pe-text:#5A6379;\n  --pe-muted:#8A92A6;\n  --pe-line:#E4E7EE;\n  --pe-soft:#F7F8FA;\n  --pe-green:#17564F;\n  --pe-bronze:#9C6B3F;\n  --pe-head:\"Josefin Sans\",\"Nunito\",-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;\n  color:var(--pe-text);\n  font-size:15px;\n  line-height:1.7;\n}\n.pe-desc *{box-sizing:border-box}\n\n.pe-lead{\n  font-size:16.5px;line-height:1.65;color:#3E465F;\n  margin:0 0 26px;padding:0 0 0 16px;\n  border-left:3px solid var(--pe-ink);\n}\n\n\/* ---- Datenkacheln ---- *\/\n.pe-chips{\n  display:grid;grid-template-columns:repeat(auto-fit,minmax(150px,1fr));\n  gap:10px;margin:0 0 30px;padding:0;list-style:none;\n}\n.pe-chips li{\n  margin:0;padding:12px 14px;\n  background:var(--pe-soft);border:1px solid var(--pe-line);border-radius:8px;\n  font-size:15px;font-weight:600;color:var(--pe-ink);line-height:1.35;\n}\n.pe-chips li b{\n  display:block;\n  font-family:var(--pe-head);\n  font-size:10.5px;font-weight:600;letter-spacing:.09em;text-transform:uppercase;\n  color:var(--pe-muted);margin:0 0 5px;\n}\n\n\/* ---- Akkordeon ---- *\/\n.pe-acc{display:flex;flex-direction:column;gap:10px;margin:0}\n.pe-acc details{\n  border:1px solid var(--pe-line);border-radius:10px;\n  background:#fff;overflow:hidden;\n}\n.pe-acc details[open]{border-color:#D3D8E5}\n.pe-acc summary{\n  cursor:pointer;list-style:none;\n  padding:15px 18px;\n  font-family:var(--pe-head);\n  font-size:15.5px;font-weight:600;letter-spacing:.005em;color:var(--pe-ink);\n  display:flex;justify-content:space-between;align-items:center;gap:14px;\n  transition:background .15s ease;\n}\n.pe-acc summary:hover{background:var(--pe-soft)}\n.pe-acc summary::-webkit-details-marker{display:none}\n.pe-acc summary::after{\n  content:\"\";flex:0 0 20px;height:20px;border-radius:50%;\n  border:1.5px solid var(--pe-line);\n  background:\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat,\n    linear-gradient(var(--pe-ink),var(--pe-ink)) center\/1.5px 9px no-repeat;\n  transition:transform .2s ease,border-color .15s ease;\n}\n.pe-acc details[open] summary{background:var(--pe-soft);border-bottom:1px solid var(--pe-line)}\n.pe-acc details[open] summary::after{\n  background:linear-gradient(var(--pe-ink),var(--pe-ink)) center\/9px 1.5px no-repeat;\n  transform:rotate(180deg);border-color:#D3D8E5;\n}\n.pe-acc .pe-body{padding:18px}\n.pe-acc .pe-body\u003ep{margin:0 0 13px}\n.pe-acc .pe-body\u003ep:last-child{margin-bottom:0}\n.pe-acc .pe-body b,.pe-acc .pe-body strong{color:var(--pe-ink);font-weight:600}\n\n.pe-acc ul{margin:0 0 13px;padding:0;list-style:none}\n.pe-acc ul:last-child{margin-bottom:0}\n.pe-acc li{\n  margin:0 0 9px;padding:0 0 0 20px;position:relative;\n}\n.pe-acc li:last-child{margin-bottom:0}\n.pe-acc li::before{\n  content:\"\";position:absolute;left:2px;top:.62em;\n  width:6px;height:6px;border-radius:50%;\n  background:var(--pe-green);\n}\n\n\/* ---- Tabellen ---- *\/\n.pe-tbl{\n  width:100%;border-collapse:collapse;font-size:14.5px;margin:0 0 13px;\n  border:1px solid var(--pe-line);border-radius:8px;overflow:hidden;\n}\n.pe-tbl:last-child{margin-bottom:0}\n.pe-tbl th,.pe-tbl td{text-align:left;padding:11px 14px;vertical-align:top;line-height:1.55}\n.pe-tbl th{\n  font-family:var(--pe-head);\n  font-weight:600;color:var(--pe-ink);width:42%;\n  background:var(--pe-soft);border-right:1px solid var(--pe-line);\n}\n.pe-tbl tr+tr th,.pe-tbl tr+tr td{border-top:1px solid var(--pe-line)}\n\n\/* ---- Schlusshinweis ---- *\/\n.pe-note{\n  margin:24px 0 0;padding:14px 16px;\n  background:var(--pe-soft);border-radius:8px;\n  border-left:3px solid var(--pe-bronze);\n  font-size:13px;line-height:1.6;color:var(--pe-muted);\n}\n\n@media (max-width:600px){\n  .pe-chips{grid-template-columns:repeat(auto-fit,minmax(128px,1fr));gap:8px}\n  .pe-chips li{padding:10px 12px;font-size:14.5px}\n  .pe-acc summary{padding:14px 15px;font-size:15px}\n  .pe-acc .pe-body{padding:15px}\n  .pe-tbl th,.pe-tbl td{padding:10px 11px;font-size:14px}\n  .pe-tbl th{width:46%}\n}\n\u003c\/style\u003e\n\u003cdiv class=\"pe-desc\"\u003e\n\u003cp class=\"pe-lead\"\u003eSculptra is Galderma's collagen stimulator based on poly-L-lactic acid (PLLA). It is not a hyaluronic acid filler: it does not provide immediate volume, but induces the neosynthesis of collagen progressively over several sessions. It is supplied as a lyophilised powder in 2 vials of 150 mg and requires reconstitution before use.\u003c\/p\u003e\n\n\u003cul class=\"pe-chips\"\u003e\n\u003cli\u003e\u003cb\u003eActive substance\u003c\/b\u003e PLLA 150 mg\/vial\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003ePresentation\u003c\/b\u003e 2 lyophilised vials\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReconstitution\u003c\/b\u003e 5\u0026ndash;8 ml of sterile water\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNeedles\u003c\/b\u003e 25G\u0026ndash;26G (18G for reconstitution)\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eProtocol\u003c\/b\u003e sessions at intervals of ≥ 4 weeks\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"pe-acc\"\u003e\n\n\u003cdetails open\u003e\n\u003csummary\u003eComposition and mechanism of action\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003ePoly-L-lactic acid (PLLA):\u003c\/b\u003e 150 mg per vial. A synthetic, biocompatible and resorbable polymer.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eSodium carboxymethylcellulose:\u003c\/b\u003e 90 mg per vial (suspending agent).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNon-pyrogenic mannitol:\u003c\/b\u003e 127.5 mg per vial (bulking agent for lyophilisation).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eMechanism:\u003c\/b\u003e Sculptra is not a hyaluronic acid filler and does not in itself provide immediate volume. The PLLA microparticles induce a controlled tissue response that stimulates collagen neosynthesis; the result is progressive and builds up over several weeks after each session. The PLLA is resorbed; the visible effect corresponds to the newly formed collagen.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eClinical consequence:\u003c\/b\u003e the product is dosed by sessions, not by immediate correction. Overcorrecting in the first session is the most frequent error, because the effect is not yet visible at that moment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eReconstitution and preparation\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eSculptra is supplied as a lyophilised powder and must be reconstituted before use.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eDiluent:\u003c\/b\u003e 5 to 8 ml of sterile water for injection per vial.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eOptional anaesthetic:\u003c\/b\u003e 1 ml of 2 % lidocaine may be added, giving a final volume of 6 to 9 ml per vial.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReconstitution needle:\u003c\/b\u003e 18G. The 18G needle is used solely to reconstitute and to draw up, never to inject.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eStanding time:\u003c\/b\u003e according to the current instructions for use, the reconstituted product may be used immediately or stored for up to 72 hours before injection.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eStorage of the reconstituted product:\u003c\/b\u003e up to 72 hours, refrigerated (2\u0026ndash;8 °C) or at room temperature (maximum 30 °C).\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eBefore drawing up:\u003c\/b\u003e shake the vial to obtain a homogeneous suspension. The homogeneity of the suspension directly determines the risk of needle blockage and of irregular deposition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eIndications and treatment areas\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003eAugmentation of facial volume in depressed areas, folds and wrinkles, and correction of facial fat loss (lipoatrophy).\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMalar region and midface\u003c\/li\u003e\n\u003cli\u003eTemporal region\u003c\/li\u003e\n\u003cli\u003eNasolabial sulcus and preauricular area\u003c\/li\u003e\n\u003cli\u003eJawline\u003c\/li\u003e\n\u003cli\u003eFacial lipoatrophy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eDo not inject\u003c\/b\u003e into the lips or into the periorbital region.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnique and session protocol\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eInjection plane:\u003c\/b\u003e deep dermis, subcutaneous tissue or supraperiosteal plane, according to the area.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eInjection needle:\u003c\/b\u003e 25G or 26G.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eTechnique:\u003c\/b\u003e linear or fanning retrograde injection, depositing in continuous movement. Avoid a static bolus and superficial placement.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eFirst session:\u003c\/b\u003e a \u003cb\u003elimited\u003c\/b\u003e correction must be performed. The result is not immediate and overcorrecting in the first session produces excess volume weeks later.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReassessment:\u003c\/b\u003e not earlier than 4 weeks after the session. Only then is it decided whether a further session is appropriate.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eNumber of sessions:\u003c\/b\u003e several sessions are usually required, with a minimum interval of 4 weeks between them. The total number depends on the degree of correction achieved at each reassessment.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eAfter treatment:\u003c\/b\u003e massage of the treated area according to the schedule indicated by the manufacturer, in order to favour homogeneous distribution of the product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eTechnical data\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003ctable class=\"pe-tbl\"\u003e\n\u003ctr\u003e\u003cth\u003eManufacturer\u003c\/th\u003e\u003ctd\u003eQ-Med AB (Galderma) \u0026mdash; Seminariegatan 21, SE-752 28 Uppsala, Sweden\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eActive substance\u003c\/th\u003e\u003ctd\u003ePoly-L-lactic acid (PLLA) 150 mg per vial\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eExcipients\u003c\/th\u003e\u003ctd\u003eSodium carboxymethylcellulose 90 mg \u0026middot; mannitol 127.5 mg per vial\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003ePresentation\u003c\/th\u003e\u003ctd\u003e2 vials of lyophilised powder for reconstitution\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eReconstitution\u003c\/th\u003e\u003ctd\u003e5\u0026ndash;8 ml of sterile water for injection (optional: +1 ml of 2 % lidocaine)\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eNeedles\u003c\/th\u003e\u003ctd\u003e18G for reconstitution \u0026middot; 25G or 26G for injection\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eTreatment plane\u003c\/th\u003e\u003ctd\u003eDeep dermis, subcutaneous or supraperiosteal\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eProtocol\u003c\/th\u003e\u003ctd\u003eLimited correction in the first session; reassessment not earlier than 4 weeks\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eClassification\u003c\/th\u003e\u003ctd\u003eCE-marked class III medical device\u003c\/td\u003e\u003c\/tr\u003e\n\u003ctr\u003e\u003cth\u003eUse\u003c\/th\u003e\u003ctd\u003eQualified healthcare professionals only\u003c\/td\u003e\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eStorage and pack contents\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cb\u003eUnopened vials:\u003c\/b\u003e store at controlled room temperature, between 15 and 30 °C, protected from heat. Do not freeze. \u003cb\u003eThey do not require refrigeration.\u003c\/b\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eReconstituted product:\u003c\/b\u003e up to 72 hours, refrigerated (2\u0026ndash;8 °C) or at room temperature (maximum 30 °C).\u003c\/li\u003e\n\u003cli\u003eDo not use after the expiry date stated on the pack.\u003c\/li\u003e\n\u003cli\u003eSingle-use product. Do not reuse or re-sterilise.\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eThe pack contains:\u003c\/b\u003e 2 single-use glass vials with 150 mg of lyophilised PLLA each and instructions for use. Sterile water for injection, lidocaine and needles are not included.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n\u003csummary\u003eContraindications and warnings\u003c\/summary\u003e\n\u003cdiv class=\"pe-body\"\u003e\n\u003cp\u003e\u003cb\u003eContraindications (Galderma instructions for use):\u003c\/b\u003e known hypersensitivity to any of the components; presence of active inflammation or infection in the area to be treated; history of severe allergies or of anaphylactic reaction.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eCaution and individual assessment:\u003c\/b\u003e history of hypertrophic or keloid scarring; coagulation disorders or anticoagulant or antiplatelet therapy; autoimmune disease; presence of permanent implants in the area.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings:\u003c\/b\u003e avoid superficial placement of the product, which is associated with the formation of subcutaneous nodules and papules. Do not inject intravascularly: intravascular injection may cause vascular occlusion, skin necrosis and serious complications, including visual disturbances or stroke. Do not inject into the lips or into the periorbital region.\u003c\/p\u003e\n\u003cp\u003eAlways consult the instructions for use included in the pack before treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/details\u003e\n\n\u003c\/div\u003e\n\n\u003cp class=\"pe-note\"\u003eMedical device intended exclusively for qualified healthcare professionals. Technical information based on the manufacturer's official documentation (instructions for use Sculptra®, Q-Med AB \/ Galderma). This information sheet does not replace the instructions for use supplied with the product.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Galderma","offers":[{"title":"Default Title","offer_id":51007638667604,"sku":null,"price":288.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0926\/8943\/2916\/files\/sculptra.jpg?v=1747685455","url":"https:\/\/pieleterna.es\/en\/products\/sculptra","provider":"Piel Eterna","version":"1.0","type":"link"}